SEC Form 4 · accession 0001127602-15-012856
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Mar 30, 2015
Accepted (ET)
Mar 31, 2015 · 8:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2015 | M | 2,592 | $52.65 | A | 2,832 | D | |
| Common StockF2 | Mar 30, 2015 | S | 900 | $176.32 | D | 1,932 | D | |
| Common StockF3 | Mar 30, 2015 | S | 892 | $177.1928 | D | 1,040 | D | |
| Common StockF4 | Mar 30, 2015 | S | 800 | $178.2556 | D | 240 | D | |
| Common Stock | Mar 30, 2015 | M | 15,327 | $53.42 | A | 548,421 | I | By Trusts |
| Common Stock | holding | — | — | — | 166 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Mar 30, 2015 | M | 2,592 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 2,592 | 505,793 | D |
| Common Stock | $53.42 | Mar 30, 2015 | M | 15,327 | D | Dec 31, 2012 | Dec 31, 2022 | Common Stock | 15,327 | 137,898 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2This transaction was executed in multiple trades at prices ranging from $175.81 to $176.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $176.90 to $177.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $178.00 to $179.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5Exercise of stock options pursuant to an "exercise and hold" transaction where none of the resulting shares were sold.